BackAmpio Pharmaceuticals Overview

Ampio Pharmaceuticals Receivables

Ampio Pharmaceuticals's receivables is $920K.

Get informed when a big investor buys or sells

+ Follow
Receivables
$920000.00

Peer trimmed avg / median

Loading

Ampio Pharmaceuticals Receivables History

Loading

Ampio Pharmaceuticals vs. peers: Receivables Comparison

Loading

Ampio Pharmaceuticals Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Ampio Pharmaceuticals (AMPE) FAQ

Ampio Pharmaceuticals (AMPE) currently reports a receivables of $920K as of December 2023. In the prior-year period, the figure was $0. Use the charts on this page to explore Ampio Pharmaceuticals's receivables history and peer comparisons.

Ampio Pharmaceuticals's receivables changed from $0 to $920K (period ending December 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Ampio Pharmaceuticals reported $920K in receivables as of December 2023. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $920K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Ampio Pharmaceuticals, and consider following AMPE for alerts when major investors trade the stock.

Ampio Pharmaceuticals is classified in the Healthcare sector. On receivables, it currently shows $920K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing AMPE with unrelated industries.